Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Schoch

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
JAAD Case Reports|February 24, 2022
Erythroderma in a neonateKristin N Smith, Elizabeth L Bisbee, Penelope J Kallis, et al.
Pain|June 13, 2023
Preclinical effects of cannabidiol in an experimental model of migraineChiara Sturaro, Bianca Fakhoury, Katarzyna M Targowska-Duda, et al.
Psychopharmacology|March 25, 2018
Differential regulation of alcohol taking and seeking by antagonism at α4β2 and α3β4 nAChRsAndrea Cippitelli, Gloria Brunori, Jennifer Schoch, et al.
Journal of Medicinal Chemistry|November 28, 2017
Highly Selective and Potent α4β2 nAChR Antagonist Inhibits Nicotine Self-Administration and Reinstatement in RatsJinhua Wu, Andrea Cippitelli, Yaohong Zhang, et al.
Pediatrics|June 24, 2024
Management of Pustules and Vesicles in Afebrile Infants ≤60 Days Evaluated by DermatologySonora Yun, Colleen Cotton, Esteban Fernandez Faith, et al.
Alcoholism, Clinical and Experimental Research|August 7, 2019
NOP Receptor Antagonists Decrease Alcohol Drinking in the Dark in C57BL/6J MiceGloria Brunori, Michelle Weger, Jennifer Schoch, et al.
British Journal of Pharmacology|December 3, 2014
AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacologyAndrea Cippitelli, Jinhua Wu, Kelly A Gaiolini, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
JAAD Case Reports|February 24, 2022
Erythroderma in a neonateKristin N Smith, Elizabeth L Bisbee, Penelope J Kallis, et al.
Pain|June 13, 2023
Preclinical effects of cannabidiol in an experimental model of migraineChiara Sturaro, Bianca Fakhoury, Katarzyna M Targowska-Duda, et al.
Psychopharmacology|March 25, 2018
Differential regulation of alcohol taking and seeking by antagonism at α4β2 and α3β4 nAChRsAndrea Cippitelli, Gloria Brunori, Jennifer Schoch, et al.
Journal of Medicinal Chemistry|November 28, 2017
Highly Selective and Potent α4β2 nAChR Antagonist Inhibits Nicotine Self-Administration and Reinstatement in RatsJinhua Wu, Andrea Cippitelli, Yaohong Zhang, et al.
Pediatrics|June 24, 2024
Management of Pustules and Vesicles in Afebrile Infants ≤60 Days Evaluated by DermatologySonora Yun, Colleen Cotton, Esteban Fernandez Faith, et al.
Alcoholism, Clinical and Experimental Research|August 7, 2019
NOP Receptor Antagonists Decrease Alcohol Drinking in the Dark in C57BL/6J MiceGloria Brunori, Michelle Weger, Jennifer Schoch, et al.
British Journal of Pharmacology|December 3, 2014
AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacologyAndrea Cippitelli, Jinhua Wu, Kelly A Gaiolini, et al.
Pageof 2